Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19

NCT04401475 is registered in ClinicalTrials.gov with Edesa Biotech Inc. as lead sponsor.

NCT NCT04401475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04401475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19
Lead sponsor
Edesa Biotech Inc.
Phase
Phase 2/3
Overall status
Terminated
Start date
November 25, 2020
Completion date
July 22, 2024
Enrollment
278 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid-19